FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Senior Member
|
After the PRECEPT trial (CEP-1347) failed in 2005, about 500 of the PRECEPT participants were recruited to join a follow-on trial named: POSTCEPT. The participants are considered a "PD control group" because when the participants joined PRECEPT, none of the them were taking PD meds AND cep-1347 didn't work so it didn't change the course of their disease progression.
I'm one of this group - and I just learned that we will be followed for 14 years in POSTCEPT! (4 years down, 10 to go...) I think that is amazing - because at the end of that time scientists will have a wealth of documented data on the progression of PD.
__________________
Jean B This isn't the life I wished for, but it is the life I have. So I'm doing my best. |
|||
![]() |
![]() |
"Thanks for this!" says: | indigogo (10-14-2009) |
|
|
![]() |
||||
Thread | Forum | |||
SCS Trial | Reflex Sympathetic Dystrophy (RSD and CRPS) | |||
ONS trial | Occipital Neuralgia and other Cranial Neuralgias | |||
Through many a trial | Sanctuary for Spiritual Support | |||
CLINICAL TRIAL...Phase III Trial with Pimavanserin in Patients with PD Psychosis | Parkinson's Disease Clinical Trials |